Keith Kaczynski
Chief Financial Officer, Matinas Biopharma
Replay available
Matinas Biopharma Holdings, Inc. (AMEX: MTNB) Q4 2022 earnings conference call, held 2023-03-15. Replay captured from the company's public earnings webcast.

Chief Financial Officer, Matinas Biopharma
Chief Executive Officer, Matinas Biopharma
Analyst, Truist Securities
Investor Relations, LHA
Chief Development Officer, Matinas Biopharma
Watch the replay and follow the connected company analysis, news, and investor updates for Matinas Biopharma Holdings, Inc..
WEBVTT 00:00:00.049 -- 00:00:03.551 Greetings and welcome to the Martinez Biopharma 2022 00:00:03.551 -- 00:00:06.153 fourth quarter and full year conference call. 00:00:06.153 -- 00:00:09.274 At this time, all participants are in a listen-only mode. 00:00:09.274 -- 00:00:12.797 A brief question and answer session will follow the formal presentation. 00:00:12.797 -- 00:00:16.359 If anyone should require operator assistance during the conference, please press star 00:00:16.359 -- 00:00:21.041 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:21.041 -- 00:00:24.123 It is now my pleasure to introduce your host, Jody Kane. 00:00:24.123 -- 00:00:27.104 Thank you, Jody. You may begin. 00:00:27.219 -- 00:00:32.580 This is Jody King with LHA. Thank you for participating in today's call. 00:00:32.580 -- 00:00:37.841 Speaking on today's call from Matinus Biopharma will be Jerry Jabbour, Chief Executive 00:00:37.841 -- 00:00:41.802 Officer, and Keith Kaczynski, Chief Financial Officer. 00:00:41.802 -- 00:00:46.563 We also have Dr. Terry Matrovich, Chief Development Officer, and Dr. 00:00:46.563 -- 00:00:51.664 Terry Ferguson, Chief Medical Officer, available to answer questions during 00:00:51.664 -- 00:00:56.705 our Q&A session. I'd like to remind listeners that remarks made during this 00:00:56.705 -- 00:01:02.755 call may state management's future intentions, hopes, beliefs, expectations, 00:01:02.755 -- 00:01:08.197 or projections. These are forward-looking statements and involve risks and uncertainties. 00:01:08.197 -- 00:01:13.279 Forward-looking statements are made pursuant to the safe harbor provisions of 00:01:13.279 -- 00:01:18.142 the federal securities law. These forward-looking statements are based on the team's 00:01:18.142 -- ...